Polymorphisms at -174 and in the 3' flanking region of interleukin-6 (IL-6) gene in patients with myasthenia gravis

Journal of Neuroimmunology

Volumn 101, Issue 2, 1999, Pages 197-200

  Huang, Deren ^a   Zheng, Chengyun ^a   Giscombe, Ricardo ^a   Matell, Georg ^b   Pirskanen, Ritva ^b   Kari Lefvert, Ann ^a  

^a The Immunological Research Unit   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Genetics; Immunoglobulin; Interleukin 6; Myasthenia gravis

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; IMMUNOGLOBULIN G; INTERLEUKIN 6;

ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MYASTHENIA GRAVIS; PRIORITY JOURNAL; SWEDEN;

AT RICH SEQUENCE; FEMALE; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN-6; MALE; MYASTHENIA GRAVIS; POLYMORPHISM, GENETIC;

EID: 0032701528     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00140-X     Document Type: Article

References (26)

1. Bowcock A.M., Ray A., Erlich H., Sehgal P.B. Rapid detection and sequencing of alleles in the 3′ flanking region of the interleukin-6 gene. Nucleic Acids Res. 17:1989;6855-6864.
2. Dedhia V., Goluszko E., Wu B., Deng C., Christadoss P. The effect of B cell deficiency on the immune response to acetylcholine receptor and the development of experimental autoimmune myasthenia gravis. Clin. Immunol. Immunopathol. 87:1998;266-275.
3. Drachman D.B. Myasthenia gravis. New Engl. J. Med. 330:1994;1797-1810.
4. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., Woo P. The effect of novel polymorphisms in the interleukin-6(IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 102:1998;1369-1376.
5. Hirano T., Yasukawa K., Harada H., Taga T., Watanabe Y., Matsuda T., Kashiwamura S., Nakajima K., Koyama K., Iwamatsu A., Tsunasawa S., Sakiyama F., Matsui H., Takahara Y., Taniguchi T., Kishimoto T. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytres to produce immunoglobulin. Nature. 324:1986;73-76.
6. Hoedemaekers A.C.W.E., Vriesman P.J.C.V.B., Baets M.H.D. Myasthenia gravis as a prototype autoimmune receptor disease. Immunol. Res. 16:1997;341-354.
7. Huang D., Pirskanen R., Hjelmström P., Lefvert A.K. Polymorphisms in IL-1β and IL-1 receptor antagonist genes are associated with myasthenia gravis. J. Neuroimmunol. 81:1998;76-81.
8. Huang D., Liu L., Norén K., Xia S., Trifunovic J., Pirskanen R., Lefvert A.K. Genetic association of Ctla-4 to myasthenia gravis with thymoma. J. Neuroimmunol. 88:1998;192-198.
9. Huang D., Xia S., Zhou Y., Pirskanen R., Liu L., Lefvert A.K. No evidence for interleukin-4 gene conferring susceptibility to myasthenia gravis. J. Neuroimmunol. 92:1998;208-211.
10. Huang D., Pirskanen R., Matell G., Lefvert A.K. Tumour necrosis factor-α polymorphism and secretion in myasthenia gravis. J. Nueroimmunol. 94:1999;165-171.
11. Ikebuchi K., Wong G.G., Clark S.C., Ihle J.N., Hirai Y., Ogawa M. Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. Proc. Natl. Acad. Sci. USA. 84:1987;9035-9039.
12. Kishore R., Tebo J.M., Kolosov M., Hamilton T.A. Clustered AU-rich elements are the target of IL-10-mediated mRNA destabilization in mouse macrophages. J. Immunol. 162:1999;2457-2461.
13. Lefvert A.K., Bergström K., Matell G., Osterman P.O., Pirkanen R. Determination of acetylcholine receptor antibodies in myasthenia gravis. J. Neurol. Neurosurg. Psychiat. 41:1978;394-403.
14. Li H., Shi F.D., He B., Bakheit M., Wahren B., Berglöf A., Sandstedt K., Link H. Experimental autoimmune myasthenia gravis induction in B cell-deficient mice. Int. Immunol. 10:1998;1359-1365.
15. Linker-Israeli M., Wallace D.J., Prehn J.L., Nand R., Li L., Klinenberg J.R. A greater variability in the 3′ flanking region of the IL-6 gene in patients with systemic lupus erythematosus (SLE). Autoimmunity. 23:1996;199-209.
16. Litt M., Luty J.A. A hypervariable microsatellite revealed by in vitro amplification of a dinucleotide repeat within the cardiac muscle actin gene. Am. J. Hum. Genet. 44:1989;397-401.
17. Muraguchi A., Hirano T., Tang B., Matsuda T., Horii Y., Nakajima K., Kishimoto T. The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J. Exp. Med. 167:1988;332-344.
18. Murray R.E., McGuigan F., Grant S.F.A., Reid D.M., Ralston S.H. Polymorphisms of the interleukin-6 gene are associated with bone mineral density. Bone. 21:1997;89-92.
19. 2-terminal sequence of a plasmacytoma growth factor derived from the murine macrophage cell line P388D1. J. Immunol. 139:1987;813-817.
20. Okada M., Sakaguchi N., Yoshimura N., Hara H., Shimizu K., Yoshida N., Yoshizaki K., Kishimoto S., Yamamura Y., Kishimoto T. B cell growth factors and B cell differentiation factor from human T hybridomas. Two distinct kinds of B cell growth factor and their synergism in B cell proliferation. J. Exp. Med. 157:1983;583-590.
21. + T cells. J. Exp. Med. 185:1997;461-469.
22. Sehgal P.B., May L.T., Tamm I. Human β2 interferon and B-cell differentiation factor BSF-2 are identical. Science. 235:1987;731-732.
23. Shaw G., Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF MRNA mediates selective MRNA degradation. Cell. 46:1986;659-667.
24. Shizuo A., Tetsuya T., Tadamitsu K. Interleukin-6 in biology and medicine. Adv. Immunol. 54:1993;1-78.
25. Suematsu S., Matsuda T., Aozasa K., Akira S., Nakano N., Ohno S., Miyazaki J.I., Yamamura K.I., Hirano T., Kishimoto T. IgG1 plasmacytosis in interleukin 6 transgenic mice. Proc. Natl. Acad. Sci. USA. 86:1989;7547-7551.
26. Weber J.L., May P.E. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am. J. Hum. Genet. 44:1989;388-396.